Guanbiao Liang

First Affiliated Hospital of GuangXi Medical University — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

7h-index217citations15works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(4), Cancer Genomics and Diagnostics(3), DNA Repair Mechanisms(2), Cancer Immunotherapy and Biomarkers(2), Lung Cancer Diagnosis and Treatment(2)

Publications15 total

Mediastinal infections: diagnostic and therapeutic advances from traditional surgery to novel minimally invasive techniques
Frontiers in Medicine·2025Open Access
Prognostic impact of surgery on thymic malignancies with concurrent or previous extrathymic malignancies: a retrospective analysis from 1998 to 2021
Journal of Cardiothoracic Surgery·2025Open Access
MIS18A upregulation promotes cell viability, migration and tumor immune evasion in lung adenocarcinoma
Oncology Letters·2024· 3 citedOpen Access
Intraventricular Thrombosis and Pulmonary Embolism Post-Nuss Procedure
CHEST Journal·2024· 1 citedOpen Access
Admission D-dimer to lymphocyte counts ratio as a novel biomarker for predicting the in-hospital mortality in patients with acute aortic dissection
BMC Cardiovascular Disorders·2023· 13 citedOpen Access
High SGO2 predicted poor prognosis and high therapeutic value of lung adenocarcinoma and promoted cell proliferation, migration, invasion, and epithelial-to-mesenchymal transformation
Journal of Cancer·2023· 3 citedOpen Access
Landscape of somatic alterations in large-scale solid tumors from an Asian population
Nature Communications·2022· 123 citedOpen Access
Early versus the traditional start of oral intake following esophagectomy for esophageal cancer: a systematic review and meta-analysis
Supportive Care in Cancer·2022· 8 cited
Abstract 4316: Frequent microsatellite instability in Chinese solid tumor patients
Cancer Research·2020
<p>Clinical Significance of Red Cell Distribution Width and Circulating Tumor Cells with an Epithelial–Mesenchymal Transition Phenotype in Lung Adenocarcinoma</p>
Cancer Management and Research·2020· 6 citedOpen Access
Clinical significance of Ki67 and circulating tumor cells with an epithelial-mesenchymal transition phenotype in non-small cell lung cancer.
PubMed·2020· 23 citedOpen Access
Responses to crizotinib and disease monitoring with circulating tumor cells in lung adenocarcinoma patient with MET exon 14 skipping mutation
Medicine·2017· 11 citedOpen Access
Association Between ERCC2 Lys751Gln Polymorphism and Lung Cancer Risk: A Meta-Analysis Involving 23,370 Subjects
Twin Research and Human Genetics·2014· 11 citedOpen Access
Quantitative assessment of the effects of the EPHX1 Tyr113His polymorphism on lung and breast cancer
Genetics and Molecular Research·2014· 11 citedOpen Access
Polymorphism of <i>ERCC2</i> Asp312Asn with Lung Cancer Risk: Evidence from 20,101 Subjects
Genetic Testing and Molecular Biomarkers·2013· 4 cited

Frequent Co-authors

Yongyong Wang(8), Mingwu Chen(7), Jianji Guo(4), Jianji Guo(3), Huajian Peng(3), Xiang Tan(3), Lei Dai(3), Xiang Tan(3), Lei Xian(3), Yansong Xu(2), Cuiqing Huang(2), Lijun Shi(2), Nuo Yang(2), Lei Dai(2), Zuotao Wu(2), Ting Zhuo(2), Yongjie Zhu(2), Zhanyu Xu(2), Liqun Wu(1), Herui Yao(1)